4DMedical (4DX) Stock Price, News & Analysis

Company Overview

4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lungs ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:4DX
• CIK: N/A
• Web: www.4dmedical.com
• Phone: 61 3 9545 5940
• Fax: N/A
• Employees: 131
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$35.98 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -50.54%
• Return on Assets: -26.95%

Debt

• Debt-to-Equity Ratio: 7.22
• Current Ratio: 1.78
• Quick Ratio: 6.01

Sales & Book Value

• Annual Sales: A$3.75 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.17 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 410,530,000
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 1.26